Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Exosomes in inflammatory tissue injury: key pathogenic factors and promising therapeutic agents

Wang Y., Ye Y., Cai D., Xu Y., Cao Y.

Narrative Review on Chronic Inflammation, published in Front Immunol (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Front Immunol (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42273693
PMCID
PMC13246361
DOI
10.3389/fimmu.2026.1830034

Abstract (original English)

Inflammation is an essential host defense mechanism but, when excessive or chronic, can cause severe tissue damage and organ dysfunction. Exosomes, a key subtype of extracellular vesicles, have emerged as critical mediators of intercellular communication by transferring bioactive cargo and modulating inflammatory signaling. This review summarizes the roles of exosomes in inflammation-associated tissue injury, focusing on their regulation of classical inflammatory pathways and programmed cell death. We further discuss the dual functions of exosomes as pathogenic mediators and therapeutic agents, highlighting their diagnostic and therapeutic potential.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsHumansInflammationAnti-Inflammatory AgentsRegenerationSignal TransductionApoptosisExosomes

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research